Bedside Wasting & e-Prescribing: Overcoming Hospice Narcotics Audits

The Bedside Compliance Challenge

Home hospice nurses manage controlled medications (morphine, oxycodone, hydromorphone, fentanyl patches, lorazepam) in living rooms, not med rooms. The clinical goal is comfort. The compliance goal is making sure those drugs end up in the patient and nowhere else, and the rules for that are less obvious than most of us assume.

The scale of the problem is not hypothetical. In a 2018 national survey of 371 hospices, 43% reported a missing opioid medication within the previous 90 days. Unused opioids were left in the home after 32% of home deaths, and 52% of agencies said their employees were not allowed to dispose of medications after a death.

Who Owns the Drugs, and Whose Rules Apply

This is where the paperwork gets confused, so it is worth being precise:

• The pharmacy is the DEA registrant. It dispenses to the patient and keeps the DEA records for that transaction.
• The patient (or family) is the ultimate user. Once dispensed, the drugs are their property. DEA recordkeeping rules under Part 1304 apply to registrants, not to a household.
• The hospice answers to Medicare. The hospice conditions of participation (42 CFR 418.106) make the hospice responsible for providing drugs related to the terminal illness, and require written policies for managing and disposing of controlled drugs in the home. When controlled drugs are first ordered, the hospice must give the family a copy of those policies, discuss them in a language and manner the family understands, and document that it did.
• States can add their own layer on top of the federal rules, and your agency policy has to meet whichever is stricter.

So the "audit" a hospice usually faces is a CMS or state survey of its policies and clinical records, plus its own diversion investigations, not a DEA inspection of the patient's nightstand.

Who May Waste and Destroy

The SUPPORT Act of 2018 added a provision to the Controlled Substances Act (21 U.S.C. 822(g)) that lets an employee of a qualified hospice handle a patient's controlled substances for on-site disposal, without a DEA registration, when:

• the patient has died,
• the drug has expired, or
• the hospice physician, who is DEA-registered, determines the patient no longer needs it because the plan of care changed.

The employee has to be licensed in the patient's state and trained by the hospice in secure disposal, and the hospice has to have the written policies and family education described above. Disposal still has to follow federal, state, and local law.

For the method, FDA's guidance is a drug take-back option first. Only if take-back is not readily available should medicines on FDA's flush list be flushed; that list includes morphine, fentanyl, hydromorphone, oxycodone, and methadone, but not lorazepam.

The Pitfalls of Paper Logs

Paper logs fail in predictable ways. A single-center review of 160 home hospice patients found only 68% of families received opioid education on admission, even though 96% had a disposal conversation at the death visit. On the staff survey, only 3 of 16 nurses said they consistently gave all of the required education to new patients. The policy existed; the documentation of it did not reliably happen.

A second signature at 0300 in a rural home is hard to get, and a count recorded from memory at the end of the shift is worth very little in an investigation.

Mobile-First Audit Logs

This is where mobile drug-tracking tools earn their place, as long as they map to the actual obligations:

• Admission education, timestamped: a record that the policy was provided and discussed, which is the CMS requirement surveyors look for.
• Bedside waste with a digital witness: drug, strength, quantity, method, and a second signature captured at the point of disposal, not reconstructed later.
• Pharmacy-to-home reconciliation: dispensed quantities matched against administrations and the final disposal, so a discrepancy surfaces in days instead of at the death visit.
• Discrepancy alerts: counts that don't reconcile get flagged to a manager while the trail is still warm.

Where e-Prescribing Fits

Electronic prescribing of controlled substances (EPCS) under 21 CFR Part 1311 closes off forged and altered paper prescriptions. CMS's EPCS program requires prescribers to send at least 70% of their Medicare Part D Schedule II–V prescriptions electronically. Drugs for the terminal diagnosis are usually covered by the hospice benefit rather than Part D, so for those the requirement that bites is often your state's EPCS law. Either way, an electronic prescription gives the reconciliation above a clean starting number.

Mitigating Risk

Moving off paper protects nurses from charting errors and agencies from survey findings, but the bigger win is diversion. Opioids left in a home after a death are a public-health problem, not just a compliance one, and the hospice employee who is trained, authorized, and documenting the disposal at the bedside is the best control we have.

Sources

• J Pain Symptom Manage (PubMed) — National survey of hospices: missing medications and opioids left in the home post-death
• Annals of Family Medicine (PMC) — Evaluation of opioid disposal process for home hospice patients
• eCFR — 42 CFR 418.106, hospice drugs and biologicals, including disposal in the home
• Cornell LII — 21 U.S.C. 822(g), disposal of controlled substances by hospice employees
• FDA — Drug disposal: FDA's flush list for certain medicines
• CMS — Electronic Prescribing for Controlled Substances (EPCS) Program